{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:47:16Z","timestamp":1793054836909,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtha.2025.09.024","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:22:58Z","timestamp":1760538178000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1383","authenticated-orcid":false,"given":"Hanny","family":"Al-Samkari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj S.","family":"Kasthuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek N.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson M.","family":"Pishko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake E.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles B.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Zumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Parambil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Carper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"McCrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.09.024_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.jtha.2025.09.024_bib2","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1002\/ajh.24832","article-title":"Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia","volume":"92","author":"Kasthuri","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.09.024_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1572-0241.2000.01792.x","article-title":"Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia","volume":"95","author":"Kjeldsen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtha.2025.09.024_bib4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000001538","article-title":"Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study","volume":"84","author":"Donaldson","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2025.09.024_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-020-01579-2","article-title":"Predictors of mortality in patients with hereditary hemorrhagic telangiectasia","volume":"16","author":"Thompson","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2025.09.024_bib6","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/bloodadvances.2023011961","article-title":"Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women","volume":"8","author":"Zhang","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.09.024_bib7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.024_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-020-1337-5","article-title":"Gender differences in hereditary hemorrhagic telangiectasia severity","volume":"15","author":"Mora-Luj\u00e1n","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2025.09.024_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104370","article-title":"The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care","volume":"65","author":"Shovlin","year":"2022","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jtha.2025.09.024_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.thromres.2017.03.003","article-title":"Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: a cross-sectional survey","volume":"153","author":"Chaturvedi","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.024_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1288\/00005537-199109000-00008","article-title":"The natural history of epistaxis in hereditary hemorrhagic telangiectasia","volume":"101","author":"AAssar","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jtha.2025.09.024_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.09.024_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.024_bib14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.024_bib15","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2352-3026(15)00195-7","article-title":"Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study","volume":"2","author":"Invernizzi","year":"2015","journal-title":"The Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.09.024_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2312749","article-title":"Pomalidomide for epistaxis in hereditary hemorrhagic telangiectasia","volume":"391","author":"Al-Samkari","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.09.024_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","article-title":"Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia","volume":"25","author":"Parambil","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jtha.2025.09.024_bib18","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2352-3026(21)00164-2","article-title":"Giving hereditary haemorrhagic telangiectasia the attention it deserves","volume":"8","author":"Al-Samkari","year":"2021","journal-title":"Lancet Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2025.09.024_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2024-206244","article-title":"A randomized, placebo-controlled, multicenter proof-of-concept (POC) study to assess the safety and efficacy of the novel allosteric AKT inhibitor, VAD044, in adults with hereditary hemorrhagic telangiectasia (HHT)","volume":"144","author":"Al-Samkari","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.024_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00435734","article-title":"Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL)","volume":"2","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jtha.2025.09.024_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13023-022-02426-2","article-title":"Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT","volume":"17","author":"Le","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2025.09.024_bib22","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/bloodadvances.2022007748","article-title":"Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument","volume":"6","author":"Kasthuri","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.09.024_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11136-004-7865-y","article-title":"Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease","volume":"13","author":"Pasculli","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jtha.2025.09.024_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","article-title":"Health-related quality of life in hereditary hemorrhagic telangiectasia","volume":"136","author":"Geisthoff","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jtha.2025.09.024_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10456-024-09962-4","article-title":"Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trial","volume":"28","author":"Hermann","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jtha.2025.09.024_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0895-4356(03)00044-1","article-title":"Defining clinically meaningful change in health-related quality of life","volume":"56","author":"Crosby","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jtha.2025.09.024_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jtha.2025.09.024_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jtha.2025.09.024_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11136-004-0705-2","article-title":"Estimating clinically significant differences in quality of life outcomes","volume":"14","author":"Wyrwich","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jtha.2025.09.024_bib30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.apmr.2015.12.010","article-title":"Evaluating individual change with the Quality of Life in Neurological Disorders (Neuro-QoL) short forms","volume":"97","author":"Kozlowski","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jtha.2025.09.024_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/jcm9010082","article-title":"Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: risk factors and endoscopic findings","volume":"9","author":"Mora-Luj\u00e1n","year":"2019","journal-title":"J Clin Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:06:01Z","timestamp":1768464361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625006166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538783625006166"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}